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ABSTRACT
We recently reported that novel ring-substituted analogs of 3,3’-diindolylmethane 
(ring-DIMs) induce apoptosis and necrosis in androgen-dependent and –independent 
prostate cancer cells. In this paper, we have focused on the mechanism(s) associated 
with ring-DIM-mediated cell death, and on identifying the specific intracellular 
target(s) of these compounds. The 4,4’- and 7,7’-dichloroDIMs and 4,4’- and 
7,7’-dibromoDIMs induced the death of LNCaP, C42B and DU145 prostate cancer cells, 
but not that of immortalized normal human prostate epithelial (RWPE-1) cells. Ring-
DIMs caused the early loss of mitochondrial membrane potential (MMP) and decreased 
mitochondrial ATP generation in prostate cancer cells. Cyclosporin A, an inhibitor 
of the mitochondrial permeability transition pore, inhibited ring-DIM-mediated cell 
death, and salubrinal, an inhibitor of ER stress, inhibited cell death mediated only by 
4,4’-dihaloDIMs. We found that although salubrinal did not inhibit the onset of ER 
stress, it prevented 4,4’-dibromoDIM mediated loss of MMP. Salubrinal potentiated 
cell death in response to 7,7’-dihaloDIMs and DIM, and this effect concurred with 
increased loss of MMP. Using in silico 3-D docking affinity analysis, we identified Ca2+/
calmodulin-dependent kinase II (CaMKII) as a potential direct target for the most toxic 
ring-DIM, 4,4’-dibromoDIM. An inhibitor of CaMKII, KN93, but not its inactive analog 
KN92, abrogated cell death mediated by 4,4’-dibromoDIM. The ring-DIMs induced ER 
stress and autophagy, but these processes were not necessary for ring-DIM-mediated 
cell death. Inhibition of autophagy with bafilomycin A1, 3-methyladenine or by LC3B 
gene silencing sensitized LNCaP and C42B, but not ATG5-deficient DU145 cells to 
ring-DIM- and DIM-mediated cell death. We propose that autophagy induced by the 
ring-DIMs and DIM has a cytoprotective function in prostate cancer cells.
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INTRODUCTION
Prostate cancer accounts for almost one third of all 
cancer deaths in the United States and is the second highest 
cause of cancer-related death in males [1]. Most prostate 
tumours are initially androgen-dependent (AD). However, 
a large contingent will progress to an aggressive androgen-
independent (AI) form, which are more drug-resistant and 
lead to increased morbidity and mortality among patients. 
Currently, prostate cancer is treated with a combination of 
radiotherapy, chemical castration, androgen receptor (AR) 
antagonists (hydroxyflutamide, bicalutamide), or inhibitors 
of steroidogenesis (abiraterone). Patients treated with 
hydroxyflutamide or bicalutamide often suffer from severe 
side-effects as a result of the anti-androgenic therapy [2, 
3], necessitating the search for novel chemotherapeutic 
agents with fewer deleterious effects. Moreover, it is 
imperative to search for novel therapeutic targets which 
may aid the development of a new generation of drugs 
effective in the elimination of AI prostate tumours. 
3,3’-Diindolylmethane (DIM) is a natural small 
molecule produced in the stomach after ingestion of 
vegetables of the Brassica family containing high amounts 
of indole-3-carbinol (I3C). I3C is converted via acid-
catalyzed reactions in the stomach to various condensation 
products, of which DIM is considered its most biologically 
active metabolite [4, 5]. DIM has been studied extensively 
as an anticancer agent due to its ability to inhibit the 
growth of a multitude of cancer cell types in vitro and in 
vivo [6, 7] and has produced positive responses in clinical 
trials for the treatment of prostate cancer when applied 
in an absorption-enhanced formulation [8]. DIM affects 
a number of distinct yet overlapping pathways, leading to 
the inhibition of cancer cell proliferation. For example, 
DIM down-regulates AR transcriptional activity, thereby 
reducing AR-mediated gene expression [9-12]. DIM also 
inhibits pro-survival cell signaling pathways such as 
phosphatidylinositide 3-kinase (PI3K), Akt, mammalian 
target of rapamycin (mTOR) and c-Met, and also activates 
pro-apoptotic pathways such as Hippo and glycogen 
synthase kinase 3-beta (GSK-3β), resulting in inhibition 
of cancer cell proliferation [13-19]. DIM activates the 
pro-apoptotic proteins Fas, FasL and death receptor 5 
(DR5), leading to caspase-dependent apoptosis [7, 9, 17, 
20]. DIM also increases the intracellular flux of calcium 
ions, resulting in the induction of endoplasmic reticulum 
(ER) stress genes [21-23], in addition to decreasing 
mitochondrial function through inhibition of ATP 
synthase [24-26], which in turn induces AMP-activated 
protein kinase-(AMPK)-dependent autophagy [27]. DIM 
also exerts effects on DNA methyltranferases, resulting 
in modified methylation patterns of genes involved in 
inflammation, cell signaling, cell motility and apoptosis 
[28]. However, the specific molecular targets that directly 
interact with DIM to cause ER stress, mitochondrial 
dysfunction, autophagy, and ultimately cell death have yet 
to be discerned.
We have previously shown that several halogenated 
analogs of DIM, termed ring-DIMs, act as anti-androgenic 
compounds that inhibit AD proliferation of LNCaP 
human prostate cancer cells and induce apoptosis and 
necrosis of AD as well as AI prostate cancer cells with 
greater potencies than DIM [11, 17]. Cell death induced 
only by the most potent ring-DIM, 4,4’-Br2DIM, was 
partially dependent on activation of caspase-3, which 
occurred concomitant with increases in Fas, FasL, DR4 
and DR5 expression. The objective of the present study 
was to determine the early events that ultimately result 
in cell death induced by 4,4’- and 7,7’-dibromo- and 
dichloro-substituted ring-DIMs and DIM by determining 
their concentration- and time-dependent effects on 
mitochondrial stability, ER stress and autophagy. We also 
performed an in silico docking affinity analysis to identify 
proteins that could potentially interact with ring-DIMs and 
DIM.
RESULTS
Ring-DIMs kill LNCaP, C42B and DU145 prostate 
cancer cells, but not RWPE-1 immortalized 
normal prostate epithelial cells
We tested the ability of the ring-DIMs to kill prostate 
cancer cells that express a DHT-responsive AR (LNCaP), 
a constitutively active AR (C42B) and cells lacking AR 
(DU145). In LNCaP and C42B cells, 4,4’-Br2DIM (IC50 
= 13.1 µM, 16.7 µM, respectively), 4,4’-Cl2DIM (IC50 
=  20.2 µM, 29.3), 7,7’-Br2DIM (IC50 =  19.5 µM, 25.3 
µM) and 7,7’-Cl2DIM (IC50 =  15.8 µM, 25.7 µM) were 
all significantly more potent at killing cells than DIM (IC50 
=  23.3, 46.1 µM), (Fig. 1A, B). The most cytotoxic ring-
DIM, 4,4’-Br2DIM, killed AR-negative DU145 cells with 
the same potency as C42B cells with an IC50 of 20 µM 
(Supplementary Fig. S1A). At concentrations that were 
toxic to the prostate cancer cells neither the ring-DIMs 
nor DIM induced cell death in RWPE-1 cells (Fig. 1C).
Mitochondrial dysfunction and ER stress are 
early events in ring-DIM induced cell death
To further investigate the mechanism of ring-DIM-
induced toxicity, we looked at MMP, mitochondrial 
ATP generation and ER stress in response to ring-
DIM exposure. After only 1 hour of exposure to the 
4,4’-dihaloDIMs, MMP decreased by 36-40% in LNCaP 
and 54-60% in C42B cells, whereas MMP decreased by 
only 30% in LNCaP and 36 % in C42B cells after a 1 
hour treatment with DIM. The 7,7’-dihaloDIMs (Fig. 2A, 
B) decreased MMP by only 15-18% in LNCaP and 16-
24% in C42B cells. The observed decreases in MMP were 
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sustained for at least 8 hours. DIM and all ring-DIMs, 
except 7,7’-Br2DIM, significantly decreased mitochondrial 
ATP generation in both cell lines by up to 80% (Fig. 2C, 
D). In DU145 cells treated with 4,4-Br2DIM, we observed 
decreases in MMP by 63% and ATP generation by 45% 
compared to controls (Supplementary Fig. S1B, C).
Treatment of LNCaP and C42B cells with 
4,4’-Br2DIM, 7,7’-Cl2DIM or DIM also caused a 
significant increase in the levels of expression of ER stress-
related proteins CHOP and ATF4 and the phosporylation 
of eIF2α between 1 and 8 hours of exposure (Fig. 2E, F). 
These results were also observed in DU145 cells using 
4,4-Br2DIM, which also increased ATF4 and CHOP levels 
after treatment for 1 to 8 hours (Supplementary Fig. S1D).
Ring-DIM-induced cell death is dependent on 
mitochondrial dysfunction
We next assessed whether CsA, an inhibitor of 
the mitochondrial permeability transition pore, could 
abrogate the toxicity of cells exposed to the ring-DIMs 
or DIM. We found that pre-treatment with 5 µM of CsA 
prevented ring-DIM-mediated loss of cell viability, but did 
not affect DIM-induced death of LNCaP or C42B cells 
(Fig. 3A, B). In LNCaP and C42B cells, CsA prevented 
the loss of MMP caused by the 4,4’-dihaloDIMs and, 
to a lesser extent, DIM, but had no effect on the loss of 
MMP mediated by the 7,7’-dihaloDIMs (Fig. 3C, D). 
We confirmed that CsA also prevented 4,4’-Br2DIM-
mediated cell death and loss of MMP in AI DU145 cells 
(Supplementary Fig. S1E and B). However, CsA had 
no effect on the phosphorylation status of eIF2α or the 
expression levels of CHOP and ATF4 in LNCaP or C42B 
cells treated with either of the three compounds (Fig. 3E-
G); this was confirmed using only 4,4’- Br2DIM in DU145 
cells (Supplementary Fig. S1F). Treatment with CsA alone 
did not affect cell viability or eIF2α phosphorylation in 
LNCaP, C42B or DU145 cells (Supplementary Fig. S2A, 
B); nor did it significantly affect MMP (Supplementary 
Fig. S2C).
Figure 1: Ring-DIMs kill LNCaP and C42B prostate 
cancer cells, but not RPWE-1 immortalized normal 
prostate epithelial cells. The percentage of intact LNCaP 
(A) and C42B (B) cells that do not have fragmented nuclei, 
condensed chromatin or propidium iodide staining was 
determined after a 24 hour exposure to increasing concentrations 
of 4,4’-Br2DIM, 7,7’-Br2DIM, 4,4’-Cl2DIM, 7,7’-Cl2DIM or 
DIM. (C) Percentage of intact RWPE-1 cells after a 48 hour 
exposure to the ring-DIMs or DIM.
Table 1: Docking affinities (kcal/mol) of DIM and its derivatives for the four isoforms of the calmodulin-dependent 
kinase II protein involved in mitochondrial metabolism and signaling pathways.
Short name Pathway PDB ID Docking affinity (kcal/mol)
4,4'-dibromo 
DIM
4,4'dichloro
DIM
7,7'-dibromo 
DIM
7,7'-dichloro 
DIM
diindolylmethane 
(DIM)
CaMK-II 
subunit α
Signal 
transduction 2VZ6/Q9UQM7 -8.8±0.0 -9.0±0.0 -8.8±0.1 -8.9±0.1 -9.2±0.0
CaMK-II 
subunit β
Signal 
transduction 3BHH/Q13554 -9.5±0.0 -9.5±0.0 -9.0±0.0 -8.9±0.1 -9.1±0.0
CaMK-II 
subunit γ
Signal 
transduction 2V7O/Q13555 -8.9±0.1 -9.1±0.0 -9.1±0.7 -8.6±0.8 -9.2±0.1
CaMK-II 
subunit δ
Signal 
transduction 2WEL/Q13557 -7.4±0.0 -7.6±0.0 -7.4±0.1 -7.7±0.1 -7.5±0.0
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Salubrinal inhibits cell death and loss of MMP but 
not ER stress mediated by 4,4’-Br2DIM
Salubrinal is an inhibitor of ER stress that blocks 
dephosphorylation of eIF2α, and we investigated the 
effects of this compound on the cytotoxicity of the ring-
DIMs and DIM. Pre-treatment of LNCaP and C42B cells 
with 20 µM of salubrinal inhibited cell death caused by 
4,4’-dihaloDIMs, but not 7,7’-dihaloDIMs or DIM (Fig 
4A, B); in DU145 cells salubrinal pre-treatment also 
completely prevented 4,4’-Br2DIM-induced cell death 
(Supplementary Fig. S1E).
In cells exposed to 4,4’-Br2DIM or 4,4’-Cl2DIM, 
pre-treatment with salubrinal attenuated the 
4,4’-dihaloDIM-mediated decrease in MMP (Fig 4C, 
D) (Supplementary Fig. S1B). Salubrinal pre-treatment 
alone did not significantly affect MMP in LNCaP, C42B 
or DU145 cells (Supplementary Fig. S2C). Using the 
most toxic of the 4,4’-dihaloDIMs as prototype, the 
4,4’-Br2DIM-mediated increase in phosphorylation of 
eIF2α was inhibited by pre-treatment with salubrinal in 
all three cell lines (Fig. 4E and Supplementary Fig. S1G). 
However, in LNCaP and C42B cells, pre-treatment with 
salubrinal did not consistently abrogate the 4,4’-Br2DIM-
induced levels of CHOP or ATF4 (Fig. 4E), and in DU145 
cells salubrinal only partially reduced the 4,4’-Br2DIM-
induced expression of these markers of ER stress 
(Supplementary Figure S1G). Salubrinal alone did not 
affect cell viability or eIF2α phosphorylation in either of 
the three cell lines (Supplementary Figure S2A, B).
Salubrinal potentiates 7,7’-dihaloDIM- and DIM-
mediated toxicity via loss of MMP
Next, we asked if salubrinal could sensitize prostate 
cancer cells to cell death induced by the 7,7’-dihaloDIMs 
and DIM. Pre-treatment of LNCaP and C42B cells with 
salubrinal enhanced the loss of cell viability caused by 
concentrations of the 7,7’-dihaloDIMs or DIM that are 
otherwise sub-toxic (defined as all cells being intact and 
not visibly Hoechst- or PI-stained) in cells that are exposed 
to the 7,7’-dihaloDIMs alone. Loss of viability mediated 
by co-treatment of LNCaP or C42B cells with salubrinal 
and sub-toxic concentrations of 7,7’-dihaloDIMs was 
attenuated by pre-treatment with CsA (Fig. 5A, B). 
Consistent with the lack of abrogation of the cytotoxicity 
Figure 2: Mitochondrial dysfunction and ER stress are early events in ring-DIM- and DIM-mediated prostate 
cancer cell death. Tetramethylrhodamine ethyl ester (TMRE) fluorescence of LNCaP (A) and C42B (B) cells after 0, 1, 4, and 8 hrs of 
exposure to 4,4’-Br2DIM, 7,7’-Br2DIM, 4,4’-Cl2DIM, 7,7’-Cl2DIM or DIM. Relative mitochondrial ATP levels of LNCaP (C) and C42B 
(D) cells treated with 5 mM 2-deoxy-D-glucose after a 1 h exposure to 4,4’-Br2DIM, 7,7’-Br2DIM, 4,4’-Cl2DIM, 7,7’-Cl2DIM or DIM. 
Phosphorylation of eIF2α, and levels of ER stress proteins were assayed by immunoblot of LNCaP (E) and C42B (F) cells after 0, 1, 4, and 
8 hrs of exposure to 4,4’-Br2DIM, 7,7’-Cl2DIM or DIM.
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Figure 3: Ring-DIM mediated cell death is dependent on the mitochondrial permeability transition pore (mPTP). 
Percentage of intact LNCaP (A) and C42B (B) cells after a 24 h exposure to 4,4’-Br2DIM, 7,7’-Br2DIM, 4,4’-Cl2DIM, 7,7’-Cl2DIM, 
or DIM with or without a 4 h pre-treatment with cyclosporin A (CsA). TMRE fluorescence of LNCaP (C) or C42B (D) cells after a 4 h 
exposure to 4,4’-Br2DIM, 7,7’-Br2DIM, 4,4’-Cl2DIM, 7,7’-Cl2DIM, or DIM with or without a 4 h pre-treatment with cyclosporin A (CsA). 
Phosphorylation of eIF2α, and levels of ER stress proteins in LNCaP and C42B cell extracts after a 24 hour exposure to 4,4’-Br2DIM (E), 
7,7’-Cl2DIM (F) or DIM (G) with or without a 4 hour pre-treatment with CsA.
Genes & Cancer270www.impactjournals.com/Genes&Cancer
of DIM by CsA alone (Fig 3A,B) CsA was also incapable 
of abrogating the cytotoxicity of DIM that was potentiated 
by pre-treatment with salubrinal (Fig. 5A, B)
LNCaP and C42B cells pre-treated with salubrinal 
and treated with either 7,7’-Br2DIM, 7,7’-Cl2DIM or DIM, 
exhibited a sharp decrease in MMP after 4 hours (Fig. 5C, 
D). Combined pre-treatment of cells with salubrinal and 
CsA partially or fully restored the loss of MMP caused by 
7,7’-Cl2DIM, 7,7’-Br2DIM and DIM (Fig 5C, D). Neither 
salubrinal nor combined salubrinal and CsA pre-treatments 
affected eIF2α phosphorylation in response to sub-toxic 
concentrations of 7,7’-dihaloDIMs or DIM as determined 
in C42B cells (Fig. 5E).
Ring-DIMs and DIM induce protective autophagy 
in prostate cancer cells
We investigated the potential of DIM and the ring-
DIMs to induce autophagy in prostate cancer cells. A dose-
Figure 4: Salubrinal modulates mitochondrial activity in prostate cancer cells treated with 4,4’-dihaloDIMs. The 
percentage of intact LNCaP (A) and C42B (B) cells was calculated after a 24 hour exposure to toxic concentrations of 4,4’-Br2DIM, 
7,7’-Br2DIM, 4,4’-Cl2DIM, 7,7’-Cl2DIM, DIM with or without a 4 h pre-treatment with salubrinal. TMRE fluorescence of LNCaP (C) 
and C42B (D) cells after a 4 hour exposure to 4,4’-Br2DIM or 4,4’-Cl2DIM with or without a 4 h pre-treatment with salubrinal. (E) 
Phosphorylation of eIF2α, and levels of ER stress proteins after a 24 hour exposure to 4,4’-Br2DIM with or without a 4 hour pre-treatment 
with salubrinal.
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Figure 5: Cyclosporin A (CsA) abrogates salubrinal-mediated sensitization of prostate cancer cells to mitochondrial 
dysfunction using sub-toxic concentrations of 7,7’-dihaloDIMs or DIM. The percentage of intact LNCaP (A) and C42B 
(B) cells pre-treated for 4 hours with salubrinal, salubrinal and CsA, or 0.3% DMSO, followed by a 24 hour exposure to mildly toxic 
concentrations of 7,7’-Br2DIM, 7,7’-Cl2DIM or DIM. TMRE fluorescence of LNCaP (C) and C42B (D) cells pre-treated for 4 hours with 
salubrinal and cyclosporin A (CsA), or 0.3% DMSO followed by a 4 hour exposure to 7,7’-Br2DIM or 7,7’-Cl2DIM. (E) Phosphorylation of 
eIF2α in C42B cell extracts after a 24 hour exposure to mildly toxic concentrations of 7,7’-Br2DIM, 7,7’-Cl2DIM or DIM with or without 
a 4 hour pre-treatment with salubrinal, salubrinal and CsA, or 0.3 % DMSO. 
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Figure 6: Ring-DIMs and DIM induce protective autophagy. (A) Levels of LC3B I and II protein in LNCaP, C42B and DU145 
cells after a 24 hr exposure to 4,4’-Br2DIM, 7,7’-Cl2DIM or DIM. Percentage of intact LNCaP (B, E),C42B (C, F) and DU145 (D, G) 
cells after a 24 h exposure to 4,4’-Br2DIM, 7,7’-Cl2DIM or DIM with or without a 4 hour pre-treatment with bafilomycin A1 (BafA1) 
or 3-methyladenine (3-MA). Percentage of intact LNCaP (H) and C42B (I) cells after a 24 hour exposure to 4,4’-Br2DIM, 7,7’-Cl2DIM 
or DIM with or without a 24 hour pre-treatment with LC3B siRNA. (J) Protein levels of LC3B I and II in LNCaP and C42B cells after 
treatment with or without LC3B siRNA.
Genes & Cancer273www.impactjournals.com/Genes&Cancer
Figure 7: KN93 abrogates 4,4’-Br2DIM mediated cell death. Percentage of intact LNCaP (A) and C42B (B) cells after a 24 hour 
exposure to 4,4’-Br2DIM, 7,7’-Cl2DIM or DIM with or without a 4 hour pre-treatment with KN92 or KN93. (C) TMRE fluorescence of 
LNCaP and C42B cells after a 4 hour exposure to 4,4’-Br2DIM with or without a 4 hour pre-treatment with KN93. (D) Phosphorylation 
of eIF2α, and levels of ER stress proteins in LNCaP and C42B cells after a 24 hour exposure to 4,4’-Br2DIM with or without a 4 hour 
pre-treatment with KN93. (E) Protein levels of Ca2+/calmodulin-dependent protein kinase (CaMKII) beta and gamma subunits in LNCaP, 
C42B and DU145 cells.
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dependent increase in LC3B conversion was observed in 
LNCaP and C42B cells, but not in autophagy-deficient 
DU145 cells, exposed to sub-toxic concentrations of 
4,4’-Br2DIM, 7,7’-Cl2DIM or DIM for 24 hours (Fig. 
6A). Pre-treatment of cells with autophagy inhibitors 
bafilomycin A1 (Fig. 6B-D) or 3-MA (Fig. 6E-G) 
sensitized LNCaP and C42B cells, but not DU145 cells, 
to sub-toxic concentrations of 4,4’-Br2DIM, 7,7’-Cl2DIM 
or DIM. We next silenced the LC3B gene in LNCaP 
and C42B cells using siRNA and then exposed them to 
sub-toxic concentrations of 4,4’-Br2DIM, 7,7’-Cl2DIM 
or DIM. We observed significant decreases in viability 
of cells treated with the LC3B-selective siRNA, but not 
control siRNA, with each of the three compounds (Fig. 
6H, I). We confirmed the effectiveness of the LC3B-
selective siRNA in decreasing the expression of LC3B 
in LNCaP and C42B cells to almost undetectable levels 
relative to control siRNA (Fig. 6J).
In silico identification of protein targets for ring-
DIMs and DIM
To identify potential molecular targets for the 
ring-DIMs and DIM, we performed in silico 3-D affinity 
docking studies of 61 proteins with known 3-D crystal 
structures and which are involved in cell survival or 
death and mitochondrial function, to determine possible 
high-affinity interactions with the 4,4’-dihaloDIMs, 
7,7’-dihaloDIMs and DIM. We identified CaMKII 
subunits alpha, beta and gamma, but not delta as possible 
high-affinity targets common to all five compounds (Table 
1). Each compound had in silico docking affinities for 
each of the subunits with free energy values less than -8.5 
kcal/mol, with a value lower than -8.0 kcal/mol considered 
a high-affinity interaction.
KN93 abrogates cell death induced by 
4,4’-Br2DIM 
The involvement of the various CaMKII subunits 
in DIM or ring-DIM-mediated toxicity in prostate 
cancer cells was assessed using a selective CaMKII 
inhibitor, KN93. In LNCaP, C42B and DU145 cells, a 
4 hour pre-treatment with KN93 resulted in a marked 
reduction of cell death caused by 4,4’-Br2DIM, but not 
7,7’-Cl2DIM or DIM (Fig. 7A-B, Supplementary Fig. 
S1E). Additionally, KN92, an inactive derivative of KN93, 
did not abrogate cell death induced by 4,4’-Br2DIM (Fig. 
7A-B, Supplementary Fig. S1E). Pre-treatment with KN93 
restored the loss of MMP caused by 4,4’-Br2DIM in all 
three prostate cancer cell lines (Fig. 7C, Supplementary 
Fig. S1B). Pre-treatment of LNCaP and C42B cells 
with KN93 reduced 4,4’-Br2DIM-mediated eIF2α 
phosphorylation, but it did not affect 4,4’-Br2DIM-
mediated increases in CHOP and ATF4 levels (Fig. 7D). 
In DU-145 cells, pre-treatment with KN93 did not alter 
the increases in eIF2α phosphorylation or levels of ATF4 
and CHOP caused by 4,4’-Br2DIM (Supplementary Fig. 
S1H). In addition, the expression of the beta and gamma 
subunits of CaMKII in LNCaP C42B, and DU145 cells 
was confirmed (Fig. 7E). The alpha and delta subunits of 
CaMKII were not found (data not shown).
DISCUSSION
Ring-DIMs kill AD and AI prostate cancer cells 
but not non-tumourigenic RWPE-1 cells
We have previously reported that ring-DIMs 
and DIM induce apoptosis and necrosis in androgen 
receptor-positive (AR+) AD LNCaP and in androgen 
receptor-negative (AR-) AI PC-3 prostate cancer cells. 
Similar to our previous report [17], 4,4’-Br2DIM induced 
cell death in AD AR+ LNCaP, AI AR+ C42B and AI 
AR- DU145 cells with the greatest potency of all five 
compounds tested. Concentrations of ring-DIMs that 
killed 100% of prostate cancer cells after  24 hours (20 
µM for 4,4’-Br2DIM, 30 µM for 7,7’-Br2DIM, 30 µM 
for 7,7’-Cl2DIM, 50 µM for 4,4’-Cl2DIM and 50 µM 
for DIM) were not toxic to non-tumourigenic RWPE-1 
prostate epithelial cells (Fig. 1). This confirms that DIM 
and its 4,4’- and 7,7’- ring-substituted analogs selectively 
affect processes and pathways that are dysregulated in 
cancerous tissues, and are not toxic to normal cells.
Cell death induced by the ring-DIMs is dependent 
on mitochondrial dysfunction but not ER stress or 
autophagy
In our previous study, we hypothesized that 
4,4’-Br2DIM induces cell death by independently 
activating both intrinsic and extrinsic apoptosis pathways 
based on the observation that this derivative activated 
caspases-8 and -9, but did not increase Bid cleavage. 
We further hypothesized that ER stress plays a role in 
ring-DIM-induced cell death, as both 4,4’-Br2DIM and 
7,7’-Cl2DIM induced increased expression of DR4 and 
DR5, and 4,4’-Br2DIM also increased Fas receptor and 
Fas ligand (FasL) [17]. Here, we show that ER stress 
and mitochondrial dysfunction are early events in ring-
DIM- and DIM-induced prostate cancer cell death. ATF4 
expression was increased by 4,4’-Br2DIM within 1 hour 
of exposure, while 7,7’-Cl2DIM and DIM increased 
ATF4 expression after 4 hours. We observed a significant 
decrease in MMP in cells treated with 4,4’-dihaloDIMs 
and DIM, but only a slight decrease in mitochondrial 
activity of cells treated with 7,7’-dihaloDIMs (Fig. 2). 
CsA, a potent inhibitor of the mitochondrial permeability 
transition pore (mPTP) complex, completely abrogated 
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ring-DIM-induced death of LNCaP and C42B cells, but 
could not prevent DIM-induced cell death (Fig. 3). CsA 
also abrogated the toxicity of 4,4’-Br2DIM in DU-145 
cells (Supplementary Figure S1B, E). The loss of MMP 
was inhibited by CsA in cells treated with the ring-DIMs 
as well as DIM, suggesting that mitochondrial dysfunction 
is necessary for cell death caused by the ring-DIMs but not 
DIM. However, pre-treatment with CsA did not abrogate 
eIF2α phosphorylation or cause a decline in the levels of 
ATF4 or CHOP in cells treated with either 4,4’-Br2DIM, 
7,7’-Cl2DIM or DIM (Fig. 3E-G). Therefore, our results 
suggest that ring-DIM-mediated ER stress is activated 
in parallel, and not downstream, of mitochondrial 
dysfunction. It has been reported previously that eIF2α 
could play a role in the survival of tumourigenic cells in 
response to Akt inhibition [39], and DIM has been shown 
to be a potent inhibitor of the Akt pathway [15, 40]. Our 
in silico data support the notion that DIM may act as a 
direct Akt inhibitor, as Akt showed a significant binding 
affinity to DIM and the ring-DIMs (Supplementary Table 
S1). Therefore, the observed induction of ER stress may 
be a pro-survival response to the mitochondrial disruption 
caused by the ring-DIMs and DIM, and is not necessary 
for ring-DIM-induced toxicity.
Although ER stress does not appear to be 
responsible for ring-DIM-induce cell death, we wished 
to confirm this using salubrinal, a compound commonly 
used to inhibit ER stress by blocking dephosphorylation 
of eIF2α. Pre-treatment with 20 µM of salubrinal inhibited 
cell death caused by 4,4’-Br2DIM and 4,4’-Cl2DIM in 
LNCaP and C42B cells, and by 4,4’-Br2DIM in DU145 
cells. In contrast, pre-treatment with salubrinal sensitized 
LNCaP and C42B cells to the toxicity of 7,7’-Br2DIM, 
7,7’-Cl2DIM and DIM (Fig. 4A, B). Interestingly, 
the increased phosphorylation of eIF2α mediated by 
4,4’-Br2DIM was abrogated by pre-treatment with 
salubrinal in all three cell lines (Fig. 4E; Supplementary 
Fig S1G). However, in LNCaP and C42B cells, pre-
treatment with salubrinal did not consistently abrogate 
the 4,4’-Br2DIM-induced levels of CHOP or ATF4 (Fig. 
4E), and in DU145 cells salubrinal only partially reduced 
the 4,4’-Br2DIM-induced expression of these markers of 
ER stress (Supplementary Fig S1G). Moreover, salubrinal 
alone did not affect phosphorylation of eIF2α in all three 
cell lines (Fig. S2A, B), suggesting that, in prostate 
cancer cells, salubrinal does not directly modify the 
phosphorylation status of eIF2α; nor does it significantly 
inhibit the onset of ring-DIM-mediated ER stress. These 
Figure 8: A schematic representation of the differential pathways activated by the 4,4’- and 7,7’-dihalogenated ring-
DIMs and their role in ring-DIM-induced prostate cancer cell death.
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results are consistent with two other reports showing 
that salubrinal did not modify the phosphorylation status 
of eIF2α, and interacted directly with Bcl-2 [41, 42]. 
We propose that the mitochondrion is a novel target of 
salubrinal which differentially modulates the disruption of 
mitochondrial stability caused by the ring-DIMs: whereas 
salubrinal abrogates 4,4’- Br2DIM-mediated loss of MMP 
(Fig. 4C, D), it exacerbates the loss of MMP induced by 
7,7’-dihaloDIMs and DIM (Fig. 5C, D). Furthermore, it 
appears that salubrinal’s ability to modulate the cell death 
caused by the ring-DIMs is dependent on the loss of 
MMP, as pre-treatment with CsA negated the synergistic 
cytotoxic effects of co-treatment with salubrinal and 
7,7’-dihaloDIMs or DIM (Fig. 5A-D). Future studies 
will investigate the mitochondrial target(s) affected 
by salubrinal, and how they may be utilized to further 
increase the cytotoxic potency of the 7,7’-dihaloDIMs and 
DIM in prostate cancer cells.
DIM has been shown to induce ER stress-dependent 
autophagy in ovarian cancer cells, with the autophagic 
response being partially responsible for DIM-mediated 
cell death in vitro and in vivo [27]. In contrast, our studies 
show that DIM- and ring-DIM-mediated autophagy is 
cytoprotective, since pre-treatment with either bafilomycin 
A1, 3-MA or transcriptional silencing of LC3B sensitized 
both LNCaP and C42B cells to cell death induced by DIM 
or the ring-DIMs. However, in DU145 cells, which are 
autophagy-deficient due to a mutation in the ATG5 gene 
leading to the premature termination of ATG5 transcripts 
[43], bafilomycin A1 and 3-MA had no effect (Fig. 6). 
Additionally, Kandala and Srivastava [27] provided 
evidence that DIM mediated autophagy was dependent on 
CHOP signalling. However, in LNCaP, C42B and DU145 
cells, ER stress was not sufficient to induce cell death in 
prostate cancer cells. Thus, it is possible that the onset of 
ER stress might also serve a cytoprotective function in 
prostate cancer cells by activating autophagy via CHOP 
signaling.
Is Ca2+/calmodulin-dependent protein kinase 
(CaMKII) involved in 4,4’-Br2DIM-mediated 
mitochondrial dysfunction?
Our in silico docking experiments revealed CaMKII 
as a potential high affinity target for the ring-DIMs and 
DIM (Table 1). In prostate cancer cells, CaMKII activity 
has been implicated in cell survival and loss of androgen-
dependence [44]. However, in a variety of cases, CaMKII 
can be pro-apoptotic and in hepatocellular carcinoma 
cells CaMKII is necessary for melittin-induced apoptosis 
[13], and CaMKII activation has been linked to sustained 
c-Jun N-terminal kinase and p38 mitogen-activated kinase 
stress signaling [13, 45, 46]. Moreover, CaMKII has been 
shown to play a role in the simultaneous induction of ER 
stress and mitochondrial dysfunction [46]. We observed 
that KN93, a selective inhibitor of CaMKII, but not its 
inactive form KN92, prevented the death of cells treated 
with 4,4’-Br2DIM, but not 7,7’-Cl2DIM or DIM (Fig. 
7A, B). In addition, KN93 abrogated the loss of MMP 
observed after exposure to 4,4’-Br2DIM and decreased 
eIF2α phosphorylation, but did not significantly prevent 
expression of ATF4 or CHOP (Fig. 7D). Thus, CaMKII 
activation may directly initiate the intrinsic pathway 
of apoptosis in prostate cancer cells, and this effect is 
independent of induction of ER stress. Interestingly, we 
found protein expression of only the beta and gamma 
subunits of CaMKII in the three prostate cancer cell 
lines tested (Fig. 7E), with both subunits exhibiting high 
docking affinity values for 4,4’-Br2DIM (Table 1). The 
crystal structure of CaMKII-beta and the docking site of 
each ring-DIM and DIM are shown in Supplementary 
Fig. S3. C42B cells have been shown to transcriptionally 
express all four subunits of CaMKII (alpha, beta, gamma, 
delta), whereas LNCaP and DU145 cells only expressed 
the beta, gamma and delta transcripts [47]. Our study 
confirms that the CaMKII-beta and -gamma proteins are 
indeed produced from these transcripts, but that protein 
levels of the CaMKII-alpha and -delta subunits are 
undetectable in each of the three cell lines. These data 
suggest that CaMKII may be a selective upstream target 
of 4,4’-Br2DIM that is responsible for the early onset 
of mitochondrial dysfunction and ER stress in prostate 
cancer cells. Although our in silico analysis identified a 
potential interaction between CaMKII and 7,7’-Cl2DIM 
and between CaMKII and DIM, it appears that CaMKII 
activity is not necessary for 7,7’-Cl2DIM- or DIM-
mediated cell death. This differential response between the 
4,4’-dihalo- and 7,7’-dihaloDIMs to inhibition of CaMKII 
by KN93 provides further evidence that the mechanisms 
of action of the ring-DIMs is highly structure-dependent. 
We previously showed that the 4,4’-dihaloDIMs, but not 
the 7,7’-dihaloDIMs induced the Fas receptor and FasL 
in LNCaP cells [17]; additionally, the 7,7’-dihaloDIMs 
were shown to be more potent inhibitors of DHT-
mediated LNCaP cell proliferation than the 4,4’-dihalo-
DIMs [17]. In the present study we also show that the 
4,4’- and 7,7’-dihaloDIMs elicit opposite responses in 
prostate cancer cells pre-treated with salubrinal, but that 
these effects are unrelated to ER stress. Moreover, pre-
treatment of all three cell lines with KN93 did not prevent 
the increase in expression of either CHOP or ATF4, 
further confirming that ER stress is not a key contributor 
to 4,4’-Br2DIM-mediated cell death.
CONCLUSION
We have confirmed that ring-substituted dihaloDIMs 
act via distinct, structure-dependent, yet overlapping 
mechanisms (Figure 8) to induce potent cytotoxic effects 
in AD and AI prostate cancer cells, but not normal prostate 
epithelium. We have shown that cell death mediated by 
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the most potent ring-DIM, 4,4’-Br2DIM, is dependent 
on CaMKII activation and subsequent mitochondrial 
dysfunction, and that ER stress is insufficient to induce 
cell death in response to either the ring-DIMs or DIM. We 
also show that the ring-DIMs and DIM induce protective 
autophagy in prostate cancer cells. Future studies will 
concentrate on the relationship between 4,4’-Br2DIM, 
CaMKII and mitochondrial dysfunction, the effectiveness 
of this potent anti-cancer compound in animal models 
of prostate cancer, and the potential for targeting the ER 
stress and autophagy pathways in order to increase the 
effectiveness of the ring-DIMs and DIM as anti-neoplastic 
agents. 
MATERIALS AND METHODS
Cell lines and reagents
LNCaP, and DU145 human prostate cancer cells as 
well as RWPE-1 immortalized normal prostate epithelial 
cells were purchased from the American Type Culture 
Collection (Manassas, VA). LNCaP C4-2B (C42B) cells 
were purchased from the MD Anderson Cancer Center 
(Houston, TX). LNCaP, C42B, DU145, and RWPE-1 
cells were grown in RPMI 1640 supplemented with 10% 
fetal bovine serum, 2 mM L-glutamine, 1% HEPES, 
1% sodium-pyruvate and 10ml/L of 100x antibiotic-
antimycotic solution (Sigma-Aldrich, St-Louis, MO). 
Cells were maintained in a humidified atmosphere (5% 
CO2) at 37oC. Ring-substituted 4,4’- and 7,7’-dihaloDIMs 
were synthesized in our laboratories at >95% purity and 
were dissolved in 100% dimethyl sulfoxide (DMSO) to 
obtain 100 mM stock solutions. Dihydrotestosterone 
(DHT; Steraloids Inc., Newport, RI) was dissolved in 
DMSO to make a 100 mM stock solution. Cyclosporin A 
(CsA; Cell Signaling, Beverly, MA), salubrinal (Enzo Life 
Sciences, Farmingdale, NY), KN92, KN93 (Millipore, 
Billerica, MA) and bafilomycin A1 (Sigma Aldrich) were 
dissolved in DMSO as 1000-fold concentrated stock 
solutions. The final concentration of DMSO in culture 
medium was 0.1% for single exposures and not greater 
than 0.3% for combined exposures.
Treatment of cells with ring-DIMs, 
pharmacological inhibitors and siRNA
LNCaP, C42B, and DU145 cells were exposed 
to the ring-DIMs at the indicated final concentrations 
in their respective culture medium, supplemented with 
2% dextran-coated charcoal-stripped FBS. DHT was 
added to LNCaP cells after serial dilution in DMSO to 
a working stock solution of 100 nM, resulting in a final 
DHT concentration of 0.1 nM in culture medium. CsA, 
KN92 and KN93, salubrinal, bafilomycin A1 were added 
to cell cultures 4 hours prior to treatment with either ring-
DIMs, DIM or DMSO vehicle control. 3-Methyladenine 
was dissolved directly in water and added freshly to the 
cells 4 hours prior to exposure to the diindolylmethane 
compounds.
For siRNA experiments, LNCaP or C42B cells 
were transfected with SMARTpool ON-TARGETplus 
siRNA oligonucleotide for LC3B (Dharmacon, USA) 
using lipofectamine RNAiMAX (Life Technologies, USA) 
in serum free Opti-MEM according to manufacturer’s 
protocols. ON-TARGETplus Non-targeting Control 
siRNAs was used a negative control. After a 24-hour 
incubation, transfected cells were exposed to the ring 
DIMs, DIM or vehicle control for a further 24 hours.
Cell death and mitochondrial membrane potential 
(MMP)
For cell death measurements, LNCaP, C42B, and 
DU145 cells were seeded in 24-well plates in 2% stripped 
FBS. Cells were then treated with (LNCaP) or without 
(C42B, DU145) 0.1 nM DHT and several concentrations 
of ring-DIMs, DIM or vehicle control (DMSO). After 24 
hours, Hoechst 33342 (Sigma-Aldrich) and propidium 
iodide (PI; Invitrogen, Carlsbad, CA) stains were both 
added to each well at a concentration of 1 µg/ml (in water) 
after which the plates were incubated for 15 minutes at 
37oC. Hoechst- and PI-positive cells were then counted 
under a Nikon Eclipse (TE-2000U) inverted fluorescence 
microscope at 20x magnification using filter cubes with 
excitation wavelengths of 330-380 and 532-587 nm, 
respectively. Intact cells were counted as exhibiting 
neither chromatin condensation, chromatin fragmentation 
nor PI staining. To measure MMP, tetramethylrhodamine 
ethyl ester (TMRE) was added to each well at a final 
concentration of 50 nM for 15 minutes at 37oC. TMRE is 
a cell permeable, positively charged dye that accumulates 
in active negatively charged mitochondria. In inactive or 
(partially) depolarized mitochondria, membranes have 
decreased potential and fail to sequester TMRE. Cells were 
then observed under an inverted fluorescence microscope 
using a filter cube with an excitation wavelength of 532-
587 nm. The photos of cells treated with either TMRE, 
Hoechst 33342 or PI were analyzed using ImageJ image 
processing software [29].
ATP measurements
LNCaP, C42B, and DU145 cells were seeded in 
96-well plates in 2% stripped-FBS. Cells were then 
treated with (LNCaP) or without (C42B, DU145) 0.1 
nM DHT and several concentrations of ring-DIMs, DIM 
or DMSO alone. A 0.5 M stock solution of 2-deoxy-D-
glucose (Sigma-Aldrich) was prepared in water and added 
to the wells at a final concentration of 5 mM 4 hours 
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prior to addition of ring-DIMs, DIM or DMSO alone. 
Mitochondrial ATP levels were measured 1 hour later 
using a ViaLight Plus kit (Lonza, Basel, Switzerland). 
Briefly, cells were treated for 10 minutes with lysis buffer, 
after which a bioluminescent ATP monitoring reagent was 
added to each well for 2 minutes. The bioluminescent 
signal was measured using a SpectroMax M5 microplate 
reader (Molecular Devices, Sunnydale, CA).
SDS-PAGE and immunoblotting
Crude protein extracts (50 µg) were resolved 
by electrophoresis in 10% sodium dodecyl sulfate-
polyacrylamide gels and then transferred to PVDF 
Immobilon-P membranes (Bio-Rad, Mississauga, ON). 
Blots were blocked using 5% milk powder (Selection 
brand, Marché Jean-Talon, Montréal, QC) and incubated 
with antibodies using a dilution of 1:500 for anti-β-actin, 
a 1:250 dilution for anti-CaMKII beta subunit and anti-
CaMKII gamma subunit (Santa Cruz Biotechnology, 
Santa Cruz, CA), a 1:500 dilution for anti-CHOP, a 
1:1000 dilution for anti-LC3B, anti-ATF4, anti-phospho 
eIF2α (Ser51), and a 1:10000 dilution for anti-eIF2α (Cell 
Signaling). Immunoreactive proteins were exposed to anti-
rabbit or anti-mouse horseradish peroxidise-conjugated 
secondary antibodies (Millipore) that were diluted 
1:5000. Antigen-antibody complexes were detected 
using Immobilon ECL Western Chemiluminescent HRP 
Substrate (Millipore) and recorded with a VersaDoc 
imaging system (Bio-Rad).
In Silico 3-D affinity docking analyses
The structures of DIM and the ring-DIMs were 
optimized in a Gaussian 09 program package (Frisch et 
al., 2004) by the Density Functional Theory (DFT) method 
at the B3LYP/6-31G level. The output file was translated 
to pdb and pdbqt formats using Open Babel [30] and 
AutoDock Tools [31], respectively. The 3-D structures of 
the proteins were downloaded from the Protein Data Bank 
(PDB) in pdb format [32]. The structure of TrailR1 was 
obtained from ModBase because its crystal structure was 
not reported in PDB. Protein structures were then prepared 
using Sybyl-X 2.0 (Tripos, St. Louis, MO). In this process, 
all ions, water molecules and other substructures were 
removed [33]. We also fixed all side-chains, backbones 
and protonation types. Once prepared, proteins underwent 
a two-step optimization procedure using Sybyl-X 2.0. The 
first step included the Powell method applying Kollman”s 
united force field AMBER (Assisted Model Building with 
Energy Refinement) charges, dielectric constant 1.0, NB 
cutoff 8.0, maximum interactions 1000 and termination 
gradient 0.001 kcal/mol. The second step utilized 
Kollman’s All Atom approach with the same parameters. 
The resultant structures were saved as pdb files and then 
converted to pdbqt format using AutoDock Tools [31]. 
Kollman charges and polar hydrogen atoms were added to 
the 3-D structures of the proteins using the same software 
[34].
Docking and docking-refinement experiments were 
carried out through a blind docking strategy by AutoDock 
Vina [35] to allow inclusion of the whole protein surface 
and all possible binding sites. The 3-D docking grid was 
centered on the macromolecule [36] and coordinates were 
calculated with a resolution of 0.357 Å using AutoDock 
Tools [31]. Docking analyses were performed with 
the AutoDock Vina 1.1 molecular docking and virtual 
screening program [35] running on a Linux operating 
system using the following settings: energy range = 1.5, 
number of modes = 20 and exhaustiveness = 25. The 
docking models of protein/DIM and protein/ring-DIM 
complexes with high-affinity scores (less than -8.0 kcal/
mol) were refined with repetitions of 100 runs to increase 
accuracy and identify alternative in silico binding sites for 
each compound.
Protein/compound complexes underwent 
conformational analyses to determine the contact residues 
and interaction type using LigandScout 3.1 software with 
default settings [37]. The interaction cutoff threshold of 
the pdb interpretation, which defines a sphere around the 
ligand, was set at 7.0 Å. The atoms of the protein found 
inside the ligand-sphere were considered to be able to 
interact with the ligand [38].
Statistical analyses
All experiments were performed in at least triplicate 
and results presented as mean ± SEM. Statistically 
significant differences (* P < 0.05, ** P < 0.01, *** P < 
0.005) were calculated using a two-tailed Student t-test. 
IC50 values were calculated using nonlinear curve-fit 
analysis. All analyses were performed using GraphPad 
Prism v5.03 (GraphPad Software, San Diego, CA).  
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